| Thu, Aug 14, 2008 |
|
Analyst Comments: SABESP, Superior Industries, Bellus Health, Amerigroup, Sonic Innovations, Petrobras, Wal-Mart, Eli Lilly
We are keeping our Buy recommendation on Companhia de Saneamento Basico do Estado de S?o Paulo, or SABESP (SBS). The company posted positive results for the second quarter of 2008, even though operating margins were lower. Net operating revenues reached R [More...]
-
home: iStockAnalyst....
|
| Fri, Jul 11, 2008 |
|
Market is Myopic on YM BioSciences
A 6-Page Stock Profile for YMI is Now Available to View or Download as a PDF at www.geocities.com/mikehavrx/YMI.pdf While the market is focused on just the pending colorectal cancer trial data; it ignores several major points on YM BioSciences:(1) the ...
-
Stock Market News & ...
|
|
Analyst Comments: Eli Lilly, St. Joe, Diamond Offshore, MannKind, Advanced Medical, The Washington Post
On July 9, Eli Lilly (LLY) announced the decision to acquire all outstanding shares of SGX Pharmaceuticals Inc (SGXP) at $3 per share. SGX shifted its focus to the FAST programs after the discontinuation of its only candidate Troxatyl for third-line acute
[More...]
-
home: iStockAnalyst....
|
| Thu, Jul 10, 2008 |
|
Another Micro-Cap Biotech Buyout
SGX Pharma (
Nasdaq: SGXP) 6-Month Chart Shares of SGX Pharma (SGXP) soared after hours Tuesday on news of an all-cash $64 million buyout from Eli Lilly (LLY). The buyout represented a premium of more than 100% at $3 per share for SGX, which is being ac...
-
Stock Market News & ...
|
| Mon, May 19, 2008 |
|
Analyst Comments: Shanda, TEPPCO, NII Holdings, Foster Wheeler, Shaw Comm, SGX Pharma
Shanda Interactive's (SNDA) revenue and earnings for the fourth quarter showed strong growth, which exceeded market expectations. We think Shanda's results demonstrate the strengths of its item-based revenue model and its comprehensive operating platform,
[More...]
-
home: iStockAnalyst....
|
|
More Blogs
|